Should I buy Elanco (ELAN) stock or is it too late?

Elanco · Health Care · price $24

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: UBS — 63% of its targets hit on this sector (119 calls tested). It aims for $33 (+35 %), call made on August 7, 2026, maturing on August 7, 2027 (21 d ago).

The 2 reliable analysts $32.50+33 %

The 4 other firms $30+23 %

How to read it: the 2 reliable firms are not filtered by optimism — 2 aim above the price, 0 below, hence their $32.50 median. “The 4 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Elanco

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Stifel	80 %	+75.2 %	10	$23 -6%
UBS	80 %	+58.8 %	5	$33 +35%
Barclays	67 %	+31.3 %	9	$30 +22%
Goldman Sachs	44 %	-6.1 %	9	$14 -43%
Morgan Stanley	38 %	-17.9 %	8	$26 +6%

In short — Should you invest in Elanco? Is it too late, still worth it? Analysts are overwhelmingly positive (83% buy, median target $31, i.e. +25%), and the most reliable on ELAN targets even higher. But it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

83% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
Median price target $31, i.e. +25% from the current price ($24).
The most reliable firm on ELAN, Citigroup (100% hit rate, 2 scored calls), targets $31 (call made on May 7, 2026, maturing on May 7, 2027) (+27%) in its most recent call, and $30 (call made on April 15, 2026, maturing on April 15, 2027) (+22%) in the one coming due soonest.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 6 ratings, 1 is neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
No dividend: your return depends only on price appreciation.

The analyst consensus on ELAN

Median target $31 (+25%) · 6 ratings · Buy consensus

Strong Buy00%

Buy583%

Hold117%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Elanco now?

We won't decide for you. The facts: 83% of analysts rate it a buy, median target $31 (+25%), and Citigroup (most reliable on ELAN, 100%) targets $31. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Elanco?

Not according to analysts: the median target ($31) is still +25% above the current price ($24) (most reliable on ELAN: Citigroup, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Elanco still worth investing in?

It depends on the gap between the price ($24) and its estimated value: analysts target $31 on median (+25%), with 83% buys (most reliable on ELAN: Citigroup, 100%). Cross-check with their real reliability on ELAN and the cautions above. Information, not advice.

What's the main risk in buying ELAN?

The consensus is not unanimous: of 6 ratings, 1 is neutral.

→ Go deeper: the full Elanco profile (consensus, analyst reliability, price target, performance).